nodes	percent_of_prediction	percent_of_DWPC	metapath
Dofetilide—CYP3A4—Ticagrelor—coronary artery disease	0.0625	0.146	CbGbCtD
Dofetilide—CYP3A4—Fenofibrate—coronary artery disease	0.0557	0.13	CbGbCtD
Dofetilide—KCNH2—purkinje fiber—coronary artery disease	0.0482	0.402	CbGeAlD
Dofetilide—CYP3A4—Gemfibrozil—coronary artery disease	0.0445	0.104	CbGbCtD
Dofetilide—CYP3A4—Clopidogrel—coronary artery disease	0.0386	0.0904	CbGbCtD
Dofetilide—CYP3A4—Eplerenone—coronary artery disease	0.0359	0.0841	CbGbCtD
Dofetilide—KCNJ12—Classical Kir channels—KCNJ2—coronary artery disease	0.0324	0.255	CbGpPWpGaD
Dofetilide—CYP3A4—Enalapril—coronary artery disease	0.032	0.0749	CbGbCtD
Dofetilide—CYP3A4—Rosuvastatin—coronary artery disease	0.0249	0.0583	CbGbCtD
Dofetilide—CYP3A4—Ezetimibe—coronary artery disease	0.0249	0.0583	CbGbCtD
Dofetilide—KCNH2—endocardium—coronary artery disease	0.0248	0.207	CbGeAlD
Dofetilide—CYP3A4—Simvastatin—coronary artery disease	0.0231	0.0542	CbGbCtD
Dofetilide—CYP3A4—Lovastatin—coronary artery disease	0.0226	0.053	CbGbCtD
Dofetilide—CYP3A4—Pravastatin—coronary artery disease	0.0226	0.053	CbGbCtD
Dofetilide—CYP3A4—Atorvastatin—coronary artery disease	0.0206	0.0483	CbGbCtD
Dofetilide—CYP3A4—Losartan—coronary artery disease	0.0189	0.0442	CbGbCtD
Dofetilide—KCNJ12—cardiac ventricle—coronary artery disease	0.0131	0.109	CbGeAlD
Dofetilide—KCNJ12—heart—coronary artery disease	0.0086	0.0718	CbGeAlD
Dofetilide—KCNJ12—Inwardly rectifying K+ channels—KCNJ8—coronary artery disease	0.0083	0.0655	CbGpPWpGaD
Dofetilide—KCNJ12—cardiovascular system—coronary artery disease	0.00811	0.0678	CbGeAlD
Dofetilide—KCNJ12—Activation of G protein gated Potassium channels—KCNJ2—coronary artery disease	0.00747	0.0589	CbGpPWpGaD
Dofetilide—KCNJ12—cardiac atrium—coronary artery disease	0.00735	0.0614	CbGeAlD
Dofetilide—KCNJ12—Inwardly rectifying K+ channels—KCNJ2—coronary artery disease	0.00629	0.0496	CbGpPWpGaD
Dofetilide—KCNJ12—Activation of GABAB receptors—KCNJ2—coronary artery disease	0.00535	0.0422	CbGpPWpGaD
Dofetilide—KCNJ12—GABA receptor activation—KCNJ2—coronary artery disease	0.0041	0.0323	CbGpPWpGaD
Dofetilide—KCNJ12—Potassium Channels—KCNJ8—coronary artery disease	0.00328	0.0259	CbGpPWpGaD
Dofetilide—KCNJ12—Potassium Channels—KCNJ2—coronary artery disease	0.00249	0.0196	CbGpPWpGaD
Dofetilide—KCNH2—cardiac ventricle—coronary artery disease	0.00209	0.0174	CbGeAlD
Dofetilide—KCNK2—Potassium Channels—KCNJ8—coronary artery disease	0.00208	0.0164	CbGpPWpGaD
Dofetilide—KCNH2—myocardium—coronary artery disease	0.00196	0.0164	CbGeAlD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—coronary artery disease	0.00188	0.0149	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—ABO—coronary artery disease	0.00182	0.0144	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—ACVR1B—coronary artery disease	0.00159	0.0125	CbGpPWpGaD
Dofetilide—KCNK2—Potassium Channels—KCNJ2—coronary artery disease	0.00158	0.0124	CbGpPWpGaD
Dofetilide—Rosiglitazone—PPARG—coronary artery disease	0.00157	0.313	CrCbGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB3—coronary artery disease	0.00144	0.0114	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—KCNJ8—coronary artery disease	0.00143	0.0113	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.00142	0.0112	CbGpPWpGaD
Dofetilide—KCNH2—heart—coronary artery disease	0.00137	0.0115	CbGeAlD
Dofetilide—KCNH2—cardiovascular system—coronary artery disease	0.00129	0.0108	CbGeAlD
Dofetilide—Dronedarone—ADRB1—coronary artery disease	0.00128	0.255	CrCbGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—ITGA2B—coronary artery disease	0.00126	0.00995	CbGpPWpGaD
Dofetilide—KCNH2—cardiac atrium—coronary artery disease	0.00117	0.0098	CbGeAlD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—FEV—coronary artery disease	0.00117	0.0092	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.00111	0.00875	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—KCNJ2—coronary artery disease	0.00109	0.00855	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.00108	0.00855	CbGpPWpGaD
Dofetilide—Rosiglitazone—CYP2C19—coronary artery disease	0.00106	0.212	CrCbGaD
Dofetilide—KCNH2—blood—coronary artery disease	0.00102	0.00855	CbGeAlD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000949	0.00748	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000913	0.00719	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—KCNJ8—coronary artery disease	0.000909	0.00717	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CAV3—coronary artery disease	0.000884	0.00697	CbGpPWpGaD
Dofetilide—KCNH2—Potassium Channels—KCNJ8—coronary artery disease	0.000882	0.00695	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000835	0.00658	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—PLCB3—coronary artery disease	0.000831	0.00655	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—EPO—coronary artery disease	0.000763	0.00602	CbGpPWpGaD
Dofetilide—CYP3A4—Liver X Receptor Pathway—ABCG5—coronary artery disease	0.000719	0.00567	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000714	0.00562	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—ALDH2—coronary artery disease	0.000699	0.00551	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—KCNJ2—coronary artery disease	0.000689	0.00543	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—BHLHE40—coronary artery disease	0.00067	0.00528	CbGpPWpGaD
Dofetilide—KCNH2—Potassium Channels—KCNJ2—coronary artery disease	0.000668	0.00527	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—CAMK2D—coronary artery disease	0.00064	0.00504	CbGpPWpGaD
Dofetilide—CYP3A4—blood—coronary artery disease	0.000634	0.0053	CbGeAlD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CREM—coronary artery disease	0.000613	0.00483	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—KCNJ8—coronary artery disease	0.000613	0.00483	CbGpPWpGaD
Dofetilide—CYP3A4—Estrogen metabolism—SULT1E1—coronary artery disease	0.0006	0.00473	CbGpPWpGaD
Dofetilide—Rosiglitazone—ALB—coronary artery disease	0.000589	0.118	CrCbGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—KITLG—coronary artery disease	0.000586	0.00462	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—STAT5A—coronary artery disease	0.000573	0.00452	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—PLCB1—coronary artery disease	0.000547	0.00431	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IL1A—coronary artery disease	0.000542	0.00427	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—RYR2—coronary artery disease	0.000536	0.00422	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—CSF2—coronary artery disease	0.000533	0.0042	CbGpPWpGaD
Dofetilide—CYP3A4—Tamoxifen metabolism—SULT1E1—coronary artery disease	0.000531	0.00418	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—PLCB3—coronary artery disease	0.000528	0.00416	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	0.00052	0.0041	CbGpPWpGaD
Dofetilide—Dronedarone—ALB—coronary artery disease	0.000512	0.102	CrCbGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—ITGB3—coronary artery disease	0.000511	0.00403	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—YBX1—coronary artery disease	0.000508	0.004	CbGpPWpGaD
Dofetilide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—coronary artery disease	0.000456	0.0036	CbGpPWpGaD
Dofetilide—CYP3A4—Estrogen metabolism—SULT1A1—coronary artery disease	0.000449	0.00354	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—ALDH2—coronary artery disease	0.000444	0.0035	CbGpPWpGaD
Dofetilide—CYP3A4—Estrogen metabolism—GSTA1—coronary artery disease	0.000439	0.00346	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HSP90B1—coronary artery disease	0.000432	0.0034	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—CAMK2D—coronary artery disease	0.000406	0.0032	CbGpPWpGaD
Dofetilide—CYP3A4—Tamoxifen metabolism—SULT1A1—coronary artery disease	0.000397	0.00313	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—CREB1—coronary artery disease	0.000391	0.00308	CbGpPWpGaD
Dofetilide—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—coronary artery disease	0.000389	0.00307	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNJ8—coronary artery disease	0.000385	0.00304	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HADHA—coronary artery disease	0.000376	0.00296	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HDAC9—coronary artery disease	0.000356	0.0028	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—PLCB1—coronary artery disease	0.000347	0.00274	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HSPD1—coronary artery disease	0.000345	0.00272	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—ALDOA—coronary artery disease	0.000317	0.0025	CbGpPWpGaD
Dofetilide—CYP3A4—Xenobiotics—CYP2C19—coronary artery disease	0.000317	0.0025	CbGpPWpGaD
Dofetilide—CYP3A4—Tamoxifen metabolism—CYP2C19—coronary artery disease	0.000305	0.0024	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—CREB1—coronary artery disease	0.000299	0.00236	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	0.000294	0.00232	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNJ2—coronary artery disease	0.000292	0.0023	CbGpPWpGaD
Dofetilide—Paraesthesia—Enalapril—coronary artery disease	0.000292	0.000907	CcSEcCtD
Dofetilide—Dyspnoea—Trandolapril—coronary artery disease	0.000291	0.000904	CcSEcCtD
Dofetilide—Insomnia—Telmisartan—coronary artery disease	0.00029	0.000901	CcSEcCtD
Dofetilide—Dyspnoea—Enalapril—coronary artery disease	0.00029	0.0009	CcSEcCtD
Dofetilide—Shock—Furosemide—coronary artery disease	0.000289	0.000899	CcSEcCtD
Dofetilide—Paraesthesia—Telmisartan—coronary artery disease	0.000288	0.000894	CcSEcCtD
Dofetilide—Pain—Pravastatin—coronary artery disease	0.000287	0.000893	CcSEcCtD
Dofetilide—Rash—Acetylsalicylic acid—coronary artery disease	0.000287	0.000892	CcSEcCtD
Dofetilide—Gastrointestinal pain—Valsartan—coronary artery disease	0.000287	0.000892	CcSEcCtD
Dofetilide—Asthenia—Clopidogrel—coronary artery disease	0.000287	0.000892	CcSEcCtD
Dofetilide—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000287	0.000891	CcSEcCtD
Dofetilide—Dyspnoea—Telmisartan—coronary artery disease	0.000286	0.000888	CcSEcCtD
Dofetilide—Gastrointestinal pain—Olmesartan—coronary artery disease	0.000285	0.000887	CcSEcCtD
Dofetilide—Asthenia—Lovastatin—coronary artery disease	0.000285	0.000886	CcSEcCtD
Dofetilide—Hyperhidrosis—Furosemide—coronary artery disease	0.000284	0.000884	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Captopril—coronary artery disease	0.000284	0.000882	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—coronary artery disease	0.000284	0.00224	CbGpPWpGaD
Dofetilide—Oedema—Losartan—coronary artery disease	0.000284	0.000882	CcSEcCtD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—coronary artery disease	0.000283	0.00223	CbGpPWpGaD
Dofetilide—Insomnia—Captopril—coronary artery disease	0.000282	0.000876	CcSEcCtD
Dofetilide—Paraesthesia—Captopril—coronary artery disease	0.00028	0.00087	CcSEcCtD
Dofetilide—Asthenia—Ezetimibe—coronary artery disease	0.000279	0.000869	CcSEcCtD
Dofetilide—Shock—Losartan—coronary artery disease	0.000279	0.000868	CcSEcCtD
Dofetilide—Gastrointestinal pain—Niacin—coronary artery disease	0.000279	0.000867	CcSEcCtD
Dofetilide—Nausea—Rosuvastatin—coronary artery disease	0.000278	0.000865	CcSEcCtD
Dofetilide—Diarrhoea—Fenofibrate—coronary artery disease	0.000278	0.000865	CcSEcCtD
Dofetilide—Dyspnoea—Captopril—coronary artery disease	0.000278	0.000863	CcSEcCtD
Dofetilide—Arrhythmia—Lisinopril—coronary artery disease	0.000277	0.000862	CcSEcCtD
Dofetilide—Abdominal pain—Valsartan—coronary artery disease	0.000277	0.000862	CcSEcCtD
Dofetilide—Abdominal pain—Olmesartan—coronary artery disease	0.000276	0.000858	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000276	0.000857	CcSEcCtD
Dofetilide—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000275	0.000854	CcSEcCtD
Dofetilide—Hyperhidrosis—Losartan—coronary artery disease	0.000274	0.000853	CcSEcCtD
Dofetilide—Pain—Telmisartan—coronary artery disease	0.000274	0.000852	CcSEcCtD
Dofetilide—Insomnia—Perindopril—coronary artery disease	0.000274	0.00085	CcSEcCtD
Dofetilide—Diarrhoea—Clopidogrel—coronary artery disease	0.000273	0.00085	CcSEcCtD
Dofetilide—Asthenia—Eplerenone—coronary artery disease	0.000273	0.00085	CcSEcCtD
Dofetilide—Angioedema—Ramipril—coronary artery disease	0.000272	0.000847	CcSEcCtD
Dofetilide—Diarrhoea—Lovastatin—coronary artery disease	0.000272	0.000845	CcSEcCtD
Dofetilide—Paraesthesia—Perindopril—coronary artery disease	0.000272	0.000844	CcSEcCtD
Dofetilide—Nausea—Acetylsalicylic acid—coronary artery disease	0.00027	0.000841	CcSEcCtD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—coronary artery disease	0.00027	0.00213	CbGpPWpGaD
Dofetilide—Dyspnoea—Perindopril—coronary artery disease	0.00027	0.000838	CcSEcCtD
Dofetilide—Abdominal pain—Niacin—coronary artery disease	0.00027	0.000838	CcSEcCtD
Dofetilide—Dizziness—Fenofibrate—coronary artery disease	0.000269	0.000836	CcSEcCtD
Dofetilide—Syncope—Ramipril—coronary artery disease	0.000267	0.000831	CcSEcCtD
Dofetilide—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000267	0.000829	CcSEcCtD
Dofetilide—Asthenia—Simvastatin—coronary artery disease	0.000266	0.000828	CcSEcCtD
Dofetilide—Diarrhoea—Ezetimibe—coronary artery disease	0.000266	0.000828	CcSEcCtD
Dofetilide—Angioedema—Timolol—coronary artery disease	0.000266	0.000828	CcSEcCtD
Dofetilide—Gastrointestinal pain—Enalapril—coronary artery disease	0.000266	0.000826	CcSEcCtD
Dofetilide—Abdominal pain—Pravastatin—coronary artery disease	0.000265	0.000825	CcSEcCtD
Dofetilide—Dizziness—Clopidogrel—coronary artery disease	0.000264	0.000822	CcSEcCtD
Dofetilide—Paraesthesia—Furosemide—coronary artery disease	0.000264	0.000821	CcSEcCtD
Dofetilide—Palpitations—Ramipril—coronary artery disease	0.000263	0.000819	CcSEcCtD
Dofetilide—Dizziness—Lovastatin—coronary artery disease	0.000263	0.000816	CcSEcCtD
Dofetilide—Loss of consciousness—Ramipril—coronary artery disease	0.000262	0.000814	CcSEcCtD
Dofetilide—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000262	0.000814	CcSEcCtD
Dofetilide—Back pain—Lisinopril—coronary artery disease	0.000261	0.000813	CcSEcCtD
Dofetilide—Syncope—Timolol—coronary artery disease	0.000261	0.000812	CcSEcCtD
Dofetilide—Diarrhoea—Eplerenone—coronary artery disease	0.000261	0.000811	CcSEcCtD
Dofetilide—Cough—Ramipril—coronary artery disease	0.00026	0.000809	CcSEcCtD
Dofetilide—Pain—Perindopril—coronary artery disease	0.000259	0.000804	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000258	0.000803	CcSEcCtD
Dofetilide—Abdominal pain—Trandolapril—coronary artery disease	0.000258	0.000801	CcSEcCtD
Dofetilide—Dizziness—Ezetimibe—coronary artery disease	0.000258	0.000801	CcSEcCtD
Dofetilide—Palpitations—Timolol—coronary artery disease	0.000257	0.0008	CcSEcCtD
Dofetilide—Abdominal pain—Enalapril—coronary artery disease	0.000257	0.000798	CcSEcCtD
Dofetilide—Insomnia—Losartan—coronary artery disease	0.000257	0.000798	CcSEcCtD
Dofetilide—Rash—Fenofibrate—coronary artery disease	0.000256	0.000797	CcSEcCtD
Dofetilide—Dermatitis—Fenofibrate—coronary artery disease	0.000256	0.000796	CcSEcCtD
Dofetilide—Loss of consciousness—Timolol—coronary artery disease	0.000256	0.000796	CcSEcCtD
Dofetilide—Headache—Fenofibrate—coronary artery disease	0.000255	0.000792	CcSEcCtD
Dofetilide—Paraesthesia—Losartan—coronary artery disease	0.000255	0.000792	CcSEcCtD
Dofetilide—Gastrointestinal pain—Captopril—coronary artery disease	0.000255	0.000792	CcSEcCtD
Dofetilide—Cough—Timolol—coronary artery disease	0.000254	0.00079	CcSEcCtD
Dofetilide—Diarrhoea—Simvastatin—coronary artery disease	0.000254	0.00079	CcSEcCtD
Dofetilide—Arthralgia—Ramipril—coronary artery disease	0.000254	0.000789	CcSEcCtD
Dofetilide—Chest pain—Ramipril—coronary artery disease	0.000254	0.000789	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL1RN—coronary artery disease	0.000253	0.002	CbGpPWpGaD
Dofetilide—Abdominal pain—Telmisartan—coronary artery disease	0.000253	0.000787	CcSEcCtD
Dofetilide—Dyspnoea—Losartan—coronary artery disease	0.000253	0.000786	CcSEcCtD
Dofetilide—Anxiety—Ramipril—coronary artery disease	0.000253	0.000786	CcSEcCtD
Dofetilide—Dizziness—Eplerenone—coronary artery disease	0.000252	0.000784	CcSEcCtD
Dofetilide—Rash—Clopidogrel—coronary artery disease	0.000252	0.000784	CcSEcCtD
Dofetilide—Dermatitis—Clopidogrel—coronary artery disease	0.000252	0.000783	CcSEcCtD
Dofetilide—Asthenia—Valsartan—coronary artery disease	0.000252	0.000782	CcSEcCtD
Dofetilide—Hypertension—Timolol—coronary artery disease	0.000252	0.000782	CcSEcCtD
Dofetilide—Pain—Furosemide—coronary artery disease	0.000251	0.000782	CcSEcCtD
Dofetilide—Asthenia—Olmesartan—coronary artery disease	0.00025	0.000779	CcSEcCtD
Dofetilide—Headache—Clopidogrel—coronary artery disease	0.00025	0.000779	CcSEcCtD
Dofetilide—Rash—Lovastatin—coronary artery disease	0.00025	0.000778	CcSEcCtD
Dofetilide—Dermatitis—Lovastatin—coronary artery disease	0.00025	0.000778	CcSEcCtD
Dofetilide—CYP3A4—Aflatoxin activation and detoxification—GGT1—coronary artery disease	0.000249	0.00196	CbGpPWpGaD
Dofetilide—Headache—Lovastatin—coronary artery disease	0.000249	0.000773	CcSEcCtD
Dofetilide—Chest pain—Timolol—coronary artery disease	0.000248	0.000771	CcSEcCtD
Dofetilide—Arthralgia—Timolol—coronary artery disease	0.000248	0.000771	CcSEcCtD
Dofetilide—Gastrointestinal pain—Perindopril—coronary artery disease	0.000247	0.000769	CcSEcCtD
Dofetilide—Anxiety—Timolol—coronary artery disease	0.000247	0.000768	CcSEcCtD
Dofetilide—Angioedema—Lisinopril—coronary artery disease	0.000247	0.000768	CcSEcCtD
Dofetilide—Abdominal pain—Captopril—coronary artery disease	0.000246	0.000766	CcSEcCtD
Dofetilide—Dizziness—Simvastatin—coronary artery disease	0.000246	0.000764	CcSEcCtD
Dofetilide—Rash—Ezetimibe—coronary artery disease	0.000246	0.000763	CcSEcCtD
Dofetilide—Dermatitis—Ezetimibe—coronary artery disease	0.000245	0.000763	CcSEcCtD
Dofetilide—Asthenia—Niacin—coronary artery disease	0.000245	0.000761	CcSEcCtD
Dofetilide—Headache—Ezetimibe—coronary artery disease	0.000244	0.000759	CcSEcCtD
Dofetilide—Oedema—Ramipril—coronary artery disease	0.000243	0.000756	CcSEcCtD
Dofetilide—Pain—Losartan—coronary artery disease	0.000243	0.000754	CcSEcCtD
Dofetilide—Syncope—Lisinopril—coronary artery disease	0.000242	0.000754	CcSEcCtD
Dofetilide—Nausea—Fenofibrate—coronary artery disease	0.000242	0.000751	CcSEcCtD
Dofetilide—Asthenia—Pravastatin—coronary artery disease	0.000241	0.000749	CcSEcCtD
Dofetilide—Gastrointestinal pain—Furosemide—coronary artery disease	0.00024	0.000747	CcSEcCtD
Dofetilide—Rash—Eplerenone—coronary artery disease	0.00024	0.000747	CcSEcCtD
Dofetilide—Dermatitis—Eplerenone—coronary artery disease	0.00024	0.000747	CcSEcCtD
Dofetilide—Diarrhoea—Valsartan—coronary artery disease	0.00024	0.000746	CcSEcCtD
Dofetilide—Shock—Ramipril—coronary artery disease	0.000239	0.000744	CcSEcCtD
Dofetilide—Abdominal pain—Perindopril—coronary artery disease	0.000239	0.000743	CcSEcCtD
Dofetilide—Palpitations—Lisinopril—coronary artery disease	0.000239	0.000743	CcSEcCtD
Dofetilide—Diarrhoea—Olmesartan—coronary artery disease	0.000239	0.000742	CcSEcCtD
Dofetilide—Headache—Eplerenone—coronary artery disease	0.000239	0.000742	CcSEcCtD
Dofetilide—Oedema—Timolol—coronary artery disease	0.000238	0.000739	CcSEcCtD
Dofetilide—Loss of consciousness—Lisinopril—coronary artery disease	0.000238	0.000739	CcSEcCtD
Dofetilide—Nausea—Clopidogrel—coronary artery disease	0.000237	0.000738	CcSEcCtD
Dofetilide—Cough—Lisinopril—coronary artery disease	0.000236	0.000733	CcSEcCtD
Dofetilide—Nausea—Lovastatin—coronary artery disease	0.000236	0.000733	CcSEcCtD
Dofetilide—Hyperhidrosis—Ramipril—coronary artery disease	0.000235	0.000731	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—ESR2—coronary artery disease	0.000235	0.00185	CbGpPWpGaD
Dofetilide—Rash—Simvastatin—coronary artery disease	0.000234	0.000728	CcSEcCtD
Dofetilide—Dermatitis—Simvastatin—coronary artery disease	0.000234	0.000727	CcSEcCtD
Dofetilide—Asthenia—Trandolapril—coronary artery disease	0.000234	0.000727	CcSEcCtD
Dofetilide—Shock—Timolol—coronary artery disease	0.000234	0.000727	CcSEcCtD
Dofetilide—Diarrhoea—Niacin—coronary artery disease	0.000233	0.000725	CcSEcCtD
Dofetilide—Asthenia—Enalapril—coronary artery disease	0.000233	0.000724	CcSEcCtD
Dofetilide—Headache—Simvastatin—coronary artery disease	0.000233	0.000723	CcSEcCtD
Dofetilide—Abdominal pain—Furosemide—coronary artery disease	0.000232	0.000723	CcSEcCtD
Dofetilide—Gastrointestinal pain—Losartan—coronary artery disease	0.000232	0.000721	CcSEcCtD
Dofetilide—Dizziness—Valsartan—coronary artery disease	0.000232	0.000721	CcSEcCtD
Dofetilide—Nausea—Ezetimibe—coronary artery disease	0.000231	0.000719	CcSEcCtD
Dofetilide—Dizziness—Olmesartan—coronary artery disease	0.000231	0.000718	CcSEcCtD
Dofetilide—Chest pain—Lisinopril—coronary artery disease	0.00023	0.000715	CcSEcCtD
Dofetilide—Arthralgia—Lisinopril—coronary artery disease	0.00023	0.000715	CcSEcCtD
Dofetilide—Hyperhidrosis—Timolol—coronary artery disease	0.00023	0.000715	CcSEcCtD
Dofetilide—Asthenia—Telmisartan—coronary artery disease	0.00023	0.000715	CcSEcCtD
Dofetilide—Diarrhoea—Pravastatin—coronary artery disease	0.00023	0.000714	CcSEcCtD
Dofetilide—Anxiety—Lisinopril—coronary artery disease	0.000229	0.000713	CcSEcCtD
Dofetilide—CYP3A4—Tryptophan metabolism—HADH—coronary artery disease	0.000227	0.00179	CbGpPWpGaD
Dofetilide—Nausea—Eplerenone—coronary artery disease	0.000226	0.000704	CcSEcCtD
Dofetilide—Dizziness—Niacin—coronary artery disease	0.000225	0.000701	CcSEcCtD
Dofetilide—Abdominal pain—Losartan—coronary artery disease	0.000224	0.000697	CcSEcCtD
Dofetilide—Asthenia—Captopril—coronary artery disease	0.000223	0.000695	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—PLCB3—coronary artery disease	0.000223	0.00176	CbGpPWpGaD
Dofetilide—Diarrhoea—Trandolapril—coronary artery disease	0.000223	0.000694	CcSEcCtD
Dofetilide—Diarrhoea—Enalapril—coronary artery disease	0.000222	0.000691	CcSEcCtD
Dofetilide—Dizziness—Pravastatin—coronary artery disease	0.000222	0.00069	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000222	0.000689	CcSEcCtD
Dofetilide—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—coronary artery disease	0.000221	0.00174	CbGpPWpGaD
Dofetilide—Rash—Valsartan—coronary artery disease	0.000221	0.000688	CcSEcCtD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—MAPK1—coronary artery disease	0.000221	0.00174	CbGpPWpGaD
Dofetilide—Dermatitis—Valsartan—coronary artery disease	0.000221	0.000687	CcSEcCtD
Dofetilide—Nausea—Simvastatin—coronary artery disease	0.000221	0.000686	CcSEcCtD
Dofetilide—Oedema—Lisinopril—coronary artery disease	0.000221	0.000686	CcSEcCtD
Dofetilide—Rash—Olmesartan—coronary artery disease	0.00022	0.000684	CcSEcCtD
Dofetilide—Insomnia—Ramipril—coronary artery disease	0.00022	0.000684	CcSEcCtD
Dofetilide—Dermatitis—Olmesartan—coronary artery disease	0.00022	0.000684	CcSEcCtD
Dofetilide—Headache—Valsartan—coronary artery disease	0.00022	0.000683	CcSEcCtD
Dofetilide—Diarrhoea—Telmisartan—coronary artery disease	0.000219	0.000681	CcSEcCtD
Dofetilide—Headache—Olmesartan—coronary artery disease	0.000219	0.00068	CcSEcCtD
Dofetilide—Paraesthesia—Ramipril—coronary artery disease	0.000218	0.000679	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—coronary artery disease	0.000218	0.00172	CbGpPWpGaD
Dofetilide—Shock—Lisinopril—coronary artery disease	0.000217	0.000675	CcSEcCtD
Dofetilide—Asthenia—Perindopril—coronary artery disease	0.000217	0.000675	CcSEcCtD
Dofetilide—Dyspnoea—Ramipril—coronary artery disease	0.000217	0.000674	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000217	0.000674	CcSEcCtD
Dofetilide—Dizziness—Trandolapril—coronary artery disease	0.000216	0.00067	CcSEcCtD
Dofetilide—Insomnia—Timolol—coronary artery disease	0.000215	0.000669	CcSEcCtD
Dofetilide—Rash—Niacin—coronary artery disease	0.000215	0.000668	CcSEcCtD
Dofetilide—Dermatitis—Niacin—coronary artery disease	0.000215	0.000668	CcSEcCtD
Dofetilide—Dizziness—Enalapril—coronary artery disease	0.000215	0.000668	CcSEcCtD
Dofetilide—CYP3A4—Estrogen metabolism—GSTM1—coronary artery disease	0.000214	0.00169	CbGpPWpGaD
Dofetilide—Headache—Niacin—coronary artery disease	0.000214	0.000664	CcSEcCtD
Dofetilide—Paraesthesia—Timolol—coronary artery disease	0.000213	0.000664	CcSEcCtD
Dofetilide—Hyperhidrosis—Lisinopril—coronary artery disease	0.000213	0.000663	CcSEcCtD
Dofetilide—Diarrhoea—Captopril—coronary artery disease	0.000213	0.000663	CcSEcCtD
Dofetilide—Dyspnoea—Timolol—coronary artery disease	0.000212	0.000659	CcSEcCtD
Dofetilide—Dizziness—Telmisartan—coronary artery disease	0.000212	0.000659	CcSEcCtD
Dofetilide—Rash—Pravastatin—coronary artery disease	0.000212	0.000658	CcSEcCtD
Dofetilide—Dermatitis—Pravastatin—coronary artery disease	0.000211	0.000658	CcSEcCtD
Dofetilide—Asthenia—Furosemide—coronary artery disease	0.000211	0.000656	CcSEcCtD
Dofetilide—Headache—Pravastatin—coronary artery disease	0.00021	0.000654	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—GJA1—coronary artery disease	0.000209	0.00165	CbGpPWpGaD
Dofetilide—Nausea—Valsartan—coronary artery disease	0.000208	0.000648	CcSEcCtD
Dofetilide—Nausea—Olmesartan—coronary artery disease	0.000207	0.000645	CcSEcCtD
Dofetilide—Diarrhoea—Perindopril—coronary artery disease	0.000207	0.000643	CcSEcCtD
Dofetilide—Dizziness—Captopril—coronary artery disease	0.000206	0.00064	CcSEcCtD
Dofetilide—Rash—Trandolapril—coronary artery disease	0.000206	0.000639	CcSEcCtD
Dofetilide—Dermatitis—Trandolapril—coronary artery disease	0.000205	0.000639	CcSEcCtD
Dofetilide—Rash—Enalapril—coronary artery disease	0.000205	0.000637	CcSEcCtD
Dofetilide—Dermatitis—Enalapril—coronary artery disease	0.000205	0.000636	CcSEcCtD
Dofetilide—Headache—Trandolapril—coronary artery disease	0.000204	0.000635	CcSEcCtD
Dofetilide—Asthenia—Losartan—coronary artery disease	0.000203	0.000633	CcSEcCtD
Dofetilide—Headache—Enalapril—coronary artery disease	0.000203	0.000633	CcSEcCtD
Dofetilide—Pain—Timolol—coronary artery disease	0.000203	0.000632	CcSEcCtD
Dofetilide—Nausea—Niacin—coronary artery disease	0.000203	0.00063	CcSEcCtD
Dofetilide—Rash—Telmisartan—coronary artery disease	0.000202	0.000628	CcSEcCtD
Dofetilide—Dermatitis—Telmisartan—coronary artery disease	0.000202	0.000627	CcSEcCtD
Dofetilide—Diarrhoea—Furosemide—coronary artery disease	0.000201	0.000625	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000201	0.000625	CcSEcCtD
Dofetilide—Headache—Telmisartan—coronary artery disease	0.000201	0.000624	CcSEcCtD
Dofetilide—Dizziness—Perindopril—coronary artery disease	0.0002	0.000622	CcSEcCtD
Dofetilide—Insomnia—Lisinopril—coronary artery disease	0.000199	0.00062	CcSEcCtD
Dofetilide—Nausea—Pravastatin—coronary artery disease	0.000199	0.00062	CcSEcCtD
Dofetilide—Gastrointestinal pain—Ramipril—coronary artery disease	0.000199	0.000618	CcSEcCtD
Dofetilide—Paraesthesia—Lisinopril—coronary artery disease	0.000198	0.000616	CcSEcCtD
Dofetilide—Dyspnoea—Lisinopril—coronary artery disease	0.000197	0.000611	CcSEcCtD
Dofetilide—Rash—Captopril—coronary artery disease	0.000196	0.000611	CcSEcCtD
Dofetilide—Dermatitis—Captopril—coronary artery disease	0.000196	0.00061	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.000196	0.00154	CbGpPWpGaD
Dofetilide—Headache—Captopril—coronary artery disease	0.000195	0.000607	CcSEcCtD
Dofetilide—Gastrointestinal pain—Timolol—coronary artery disease	0.000194	0.000604	CcSEcCtD
Dofetilide—Dizziness—Furosemide—coronary artery disease	0.000194	0.000604	CcSEcCtD
Dofetilide—Diarrhoea—Losartan—coronary artery disease	0.000194	0.000603	CcSEcCtD
Dofetilide—Nausea—Trandolapril—coronary artery disease	0.000194	0.000602	CcSEcCtD
Dofetilide—Nausea—Enalapril—coronary artery disease	0.000193	0.0006	CcSEcCtD
Dofetilide—Abdominal pain—Ramipril—coronary artery disease	0.000192	0.000598	CcSEcCtD
Dofetilide—Rash—Perindopril—coronary artery disease	0.000191	0.000593	CcSEcCtD
Dofetilide—Dermatitis—Perindopril—coronary artery disease	0.00019	0.000592	CcSEcCtD
Dofetilide—Nausea—Telmisartan—coronary artery disease	0.00019	0.000592	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—CREB1—coronary artery disease	0.00019	0.0015	CbGpPWpGaD
Dofetilide—Headache—Perindopril—coronary artery disease	0.000189	0.000589	CcSEcCtD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B2—coronary artery disease	0.000189	0.00149	CbGpPWpGaD
Dofetilide—Pain—Lisinopril—coronary artery disease	0.000189	0.000586	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—ALDH2—coronary artery disease	0.000188	0.00148	CbGpPWpGaD
Dofetilide—Abdominal pain—Timolol—coronary artery disease	0.000188	0.000584	CcSEcCtD
Dofetilide—Dizziness—Losartan—coronary artery disease	0.000188	0.000583	CcSEcCtD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP11B2—coronary artery disease	0.000186	0.00147	CbGpPWpGaD
Dofetilide—Rash—Furosemide—coronary artery disease	0.000185	0.000576	CcSEcCtD
Dofetilide—Dermatitis—Furosemide—coronary artery disease	0.000185	0.000576	CcSEcCtD
Dofetilide—Nausea—Captopril—coronary artery disease	0.000185	0.000575	CcSEcCtD
Dofetilide—Headache—Furosemide—coronary artery disease	0.000184	0.000573	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.000182	0.00144	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.000181	0.00143	CbGpPWpGaD
Dofetilide—Gastrointestinal pain—Lisinopril—coronary artery disease	0.00018	0.000561	CcSEcCtD
Dofetilide—Nausea—Perindopril—coronary artery disease	0.00018	0.000558	CcSEcCtD
Dofetilide—Rash—Losartan—coronary artery disease	0.000179	0.000556	CcSEcCtD
Dofetilide—Dermatitis—Losartan—coronary artery disease	0.000179	0.000556	CcSEcCtD
Dofetilide—Headache—Losartan—coronary artery disease	0.000178	0.000552	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.000176	0.00139	CbGpPWpGaD
Dofetilide—Nausea—Furosemide—coronary artery disease	0.000175	0.000543	CcSEcCtD
Dofetilide—Asthenia—Ramipril—coronary artery disease	0.000174	0.000543	CcSEcCtD
Dofetilide—Abdominal pain—Lisinopril—coronary artery disease	0.000174	0.000542	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—CAMK2D—coronary artery disease	0.000172	0.00136	CbGpPWpGaD
Dofetilide—Asthenia—Timolol—coronary artery disease	0.000171	0.00053	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—MAPK1—coronary artery disease	0.000169	0.00133	CbGpPWpGaD
Dofetilide—Nausea—Losartan—coronary artery disease	0.000168	0.000524	CcSEcCtD
Dofetilide—CYP3A4—Tryptophan metabolism—ALDH2—coronary artery disease	0.000167	0.00132	CbGpPWpGaD
Dofetilide—Diarrhoea—Ramipril—coronary artery disease	0.000166	0.000517	CcSEcCtD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—coronary artery disease	0.000165	0.0013	CbGpPWpGaD
Dofetilide—Diarrhoea—Timolol—coronary artery disease	0.000163	0.000506	CcSEcCtD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—coronary artery disease	0.000161	0.00127	CbGpPWpGaD
Dofetilide—Dizziness—Ramipril—coronary artery disease	0.000161	0.0005	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	0.000161	0.00127	CbGpPWpGaD
Dofetilide—Asthenia—Lisinopril—coronary artery disease	0.000158	0.000492	CcSEcCtD
Dofetilide—Dizziness—Timolol—coronary artery disease	0.000157	0.000489	CcSEcCtD
Dofetilide—Rash—Ramipril—coronary artery disease	0.000153	0.000477	CcSEcCtD
Dofetilide—Dermatitis—Ramipril—coronary artery disease	0.000153	0.000476	CcSEcCtD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—coronary artery disease	0.000153	0.00121	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	0.000153	0.00121	CbGpPWpGaD
Dofetilide—Headache—Ramipril—coronary artery disease	0.000152	0.000474	CcSEcCtD
Dofetilide—Diarrhoea—Lisinopril—coronary artery disease	0.000151	0.000469	CcSEcCtD
Dofetilide—Rash—Timolol—coronary artery disease	0.00015	0.000466	CcSEcCtD
Dofetilide—Dermatitis—Timolol—coronary artery disease	0.00015	0.000466	CcSEcCtD
Dofetilide—Headache—Timolol—coronary artery disease	0.000149	0.000463	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—PLCB1—coronary artery disease	0.000147	0.00116	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—SULT4A1—coronary artery disease	0.000146	0.00115	CbGpPWpGaD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—coronary artery disease	0.000146	0.00115	CbGpPWpGaD
Dofetilide—Dizziness—Lisinopril—coronary artery disease	0.000146	0.000453	CcSEcCtD
Dofetilide—Nausea—Ramipril—coronary artery disease	0.000144	0.000449	CcSEcCtD
Dofetilide—CYP3A4—Metapathway biotransformation—SULT4A1—coronary artery disease	0.000144	0.00114	CbGpPWpGaD
Dofetilide—Nausea—Timolol—coronary artery disease	0.000141	0.000439	CcSEcCtD
Dofetilide—Rash—Lisinopril—coronary artery disease	0.000139	0.000432	CcSEcCtD
Dofetilide—Dermatitis—Lisinopril—coronary artery disease	0.000139	0.000432	CcSEcCtD
Dofetilide—Headache—Lisinopril—coronary artery disease	0.000138	0.00043	CcSEcCtD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—coronary artery disease	0.000132	0.00104	CbGpPWpGaD
Dofetilide—Nausea—Lisinopril—coronary artery disease	0.000131	0.000407	CcSEcCtD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—coronary artery disease	0.00013	0.00102	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CREB1—coronary artery disease	0.000128	0.00101	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL6R—coronary artery disease	0.000125	0.000986	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—coronary artery disease	0.000109	0.000863	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—MAPK1—coronary artery disease	0.000108	0.000848	CbGpPWpGaD
Dofetilide—CYP3A4—Tryptophan metabolism—CAT—coronary artery disease	0.000107	0.000845	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—coronary artery disease	0.000107	0.000841	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTM2—coronary artery disease	0.000104	0.000821	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTM2—coronary artery disease	0.000103	0.000809	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	9.92e-05	0.000782	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—SULT1E1—coronary artery disease	9.87e-05	0.000778	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—SULT1E1—coronary artery disease	9.73e-05	0.000767	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL1B—coronary artery disease	9.51e-05	0.00075	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CASP3—coronary artery disease	9.49e-05	0.000748	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—AKR1B1—coronary artery disease	9.28e-05	0.000732	CbGpPWpGaD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—coronary artery disease	9.24e-05	0.000728	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GCLM—coronary artery disease	8.39e-05	0.000661	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP11B2—coronary artery disease	8.13e-05	0.000641	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	8.05e-05	0.000635	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—CREB1—coronary artery disease	8.05e-05	0.000635	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP11B2—coronary artery disease	8.01e-05	0.000632	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—SULT1A1—coronary artery disease	7.39e-05	0.000582	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GPX2—coronary artery disease	7.38e-05	0.000581	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—SULT1A1—coronary artery disease	7.29e-05	0.000574	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GPX4—coronary artery disease	7.29e-05	0.000574	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTA1—coronary artery disease	7.22e-05	0.000569	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—TNF—coronary artery disease	6.9e-05	0.000544	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GPX3—coronary artery disease	5.98e-05	0.000472	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—ALDH2—coronary artery disease	5.82e-05	0.000458	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	5.78e-05	0.000456	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP2C19—coronary artery disease	5.67e-05	0.000447	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP2C19—coronary artery disease	5.59e-05	0.000441	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL6—coronary artery disease	5.57e-05	0.000439	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTT1—coronary artery disease	5.53e-05	0.000436	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GCLC—coronary artery disease	5.47e-05	0.000431	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	4.69e-05	0.00037	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—MAPK1—coronary artery disease	4.55e-05	0.000359	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GGT1—coronary artery disease	4.27e-05	0.000337	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CA5B—coronary artery disease	3.88e-05	0.000306	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	3.83e-05	0.000302	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	3.78e-05	0.000298	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	3.52e-05	0.000278	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	3.48e-05	0.000274	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CKMT1B—coronary artery disease	3.3e-05	0.00026	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPAP2B—coronary artery disease	2.69e-05	0.000212	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CKM—coronary artery disease	2.69e-05	0.000212	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	2.69e-05	0.000212	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	2.5e-05	0.000197	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CKMT2—coronary artery disease	2.5e-05	0.000197	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PDK4—coronary artery disease	2.5e-05	0.000197	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PYGM—coronary artery disease	2.5e-05	0.000197	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SULT4A1—coronary artery disease	2.5e-05	0.000197	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—POMC—coronary artery disease	2.49e-05	0.000196	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—LDHA—coronary artery disease	2.23e-05	0.000176	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GYG1—coronary artery disease	2.23e-05	0.000176	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HMGCS2—coronary artery disease	2.23e-05	0.000176	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GK—coronary artery disease	2.23e-05	0.000176	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PFKM—coronary artery disease	2.23e-05	0.000176	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GATM—coronary artery disease	2.23e-05	0.000176	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GCH1—coronary artery disease	2.12e-05	0.000167	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AK1—coronary artery disease	2.12e-05	0.000167	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—MDH2—coronary artery disease	2.04e-05	0.000161	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—UGCG—coronary artery disease	2.04e-05	0.000161	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPAT—coronary artery disease	2.04e-05	0.000161	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PLCD1—coronary artery disease	2.04e-05	0.000161	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PGM1—coronary artery disease	1.96e-05	0.000155	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PYGB—coronary artery disease	1.89e-05	0.000149	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CKB—coronary artery disease	1.89e-05	0.000149	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.78e-05	0.00014	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—DLAT—coronary artery disease	1.78e-05	0.00014	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.78e-05	0.00014	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—COX5B—coronary artery disease	1.78e-05	0.00014	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.78e-05	0.00014	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.69e-05	0.000133	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.61e-05	0.000127	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HK2—coronary artery disease	1.61e-05	0.000127	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.54e-05	0.000122	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.51e-05	0.000119	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—LCAT—coronary artery disease	1.51e-05	0.000119	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOA4—coronary artery disease	1.49e-05	0.000117	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.43e-05	0.000113	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GCLM—coronary artery disease	1.43e-05	0.000113	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.39e-05	0.00011	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.39e-05	0.00011	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.37e-05	0.000108	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HADH—coronary artery disease	1.35e-05	0.000106	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.35e-05	0.000106	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.28e-05	0.000101	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOA2—coronary artery disease	1.28e-05	0.000101	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GPX2—coronary artery disease	1.28e-05	0.000101	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.26e-05	9.96e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HK1—coronary artery disease	1.26e-05	9.96e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GPX4—coronary artery disease	1.26e-05	9.96e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.26e-05	9.96e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HADHA—coronary artery disease	1.25e-05	9.84e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.23e-05	9.73e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—LPA—coronary artery disease	1.22e-05	9.62e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.18e-05	9.32e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOA5—coronary artery disease	1.17e-05	9.22e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—P4HB—coronary artery disease	1.15e-05	9.04e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.13e-05	8.88e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—VCAN—coronary artery disease	1.06e-05	8.37e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.05e-05	8.3e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—DCN—coronary artery disease	1.02e-05	8.06e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALDH2—coronary artery disease	9.95e-06	7.84e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP2C19—coronary artery disease	9.69e-06	7.64e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	9.69e-06	7.64e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HBA1—coronary artery disease	9.69e-06	7.64e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—LIPC—coronary artery disease	9.69e-06	7.64e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOC3—coronary artery disease	9.63e-06	7.59e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—LDLR—coronary artery disease	9.57e-06	7.55e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC9A1—coronary artery disease	9.46e-06	7.46e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTT1—coronary artery disease	9.46e-06	7.46e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CETP—coronary artery disease	9.35e-06	7.37e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GCLC—coronary artery disease	9.35e-06	7.37e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SDC1—coronary artery disease	9.25e-06	7.29e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PSMB5—coronary artery disease	8.74e-06	6.89e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PSMA6—coronary artery disease	8.74e-06	6.89e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CTGF—coronary artery disease	8.53e-06	6.73e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GOT2—coronary artery disease	8.46e-06	6.67e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HMGCR—coronary artery disease	8.46e-06	6.67e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PLCB1—coronary artery disease	7.78e-06	6.13e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCA1—coronary artery disease	7.54e-06	5.94e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GGT1—coronary artery disease	7.3e-06	5.76e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GOT1—coronary artery disease	7.3e-06	5.76e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTP1—coronary artery disease	6.56e-06	5.17e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	6.5e-06	5.12e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HMOX1—coronary artery disease	6.47e-06	5.1e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CAT—coronary artery disease	6.38e-06	5.03e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOB—coronary artery disease	6.19e-06	4.88e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTM1—coronary artery disease	6.03e-06	4.75e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—LPL—coronary artery disease	5.91e-06	4.66e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GPX1—coronary artery disease	5.77e-06	4.55e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CD36—coronary artery disease	5.62e-06	4.43e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	5.55e-06	4.38e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—MTHFR—coronary artery disease	5.33e-06	4.2e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AGT—coronary artery disease	5.06e-06	3.99e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOE—coronary artery disease	4.96e-06	3.91e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOA1—coronary artery disease	4.9e-06	3.86e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPARG—coronary artery disease	4.32e-06	3.4e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—POMC—coronary artery disease	4.26e-06	3.36e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALB—coronary artery disease	3.88e-06	3.06e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NOS3—coronary artery disease	3.71e-06	2.93e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.4e-06	2.68e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.09e-06	1.65e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKT1—coronary artery disease	1.71e-06	1.35e-05	CbGpPWpGaD
